Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20024
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPal, Bhupinder-
dc.contributor.authorAnderson, Robin L-
dc.date2018-11-06-
dc.date.accessioned2019-01-02T01:14:45Z-
dc.date.available2019-01-02T01:14:45Z-
dc.date.issued2018-11-06-
dc.identifier.citationOncotarget 2018; 9(87): 35717-35718-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/20024-
dc.language.isoeng-
dc.subjectBRCA1-
dc.subjectbasal breast cancer-
dc.subjectmiRNA-
dc.titleMiRNAs prognostic for basal and BRCA1 breast cancer.-
dc.typeJournal Article-
dc.identifier.journaltitleOncotarget-
dc.identifier.affiliationTranslational Breast Cancer Program, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Bundoora, Australiaen
dc.identifier.doi10.18632/oncotarget.26297-
dc.identifier.orcid0000-0002-6841-7422-
dc.identifier.pubmedid30515261-
dc.type.austinNews-
dc.type.austinComment-
local.name.researcherAnderson, Robin L
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Jan 9, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.